Celularity Inc. Form DEFA14A: Additional definitive proxy soliciting materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-11-07: Form DEFA14A; Description DEFA14A; Document formdefa14a.htm.
- 2021-05-10: Form DEFA14A; Description CURRENT REPORT; Document ea140562-8k_gxacquisition.htm.
- 2021-04-16: Form DEFA14A; Description CURRENT REPORT; Document ea139580-8k_gxacqcorp.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-11-07 | DEFA14A | DEFA14A | formdefa14a.htm | |
| 2021-05-10 | DEFA14A | CURRENT REPORT | ea140562-8k_gxacquisition.htm | |
| 2021-04-16 | DEFA14A | CURRENT REPORT | ea139580-8k_gxacqcorp.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |